VBS — Vectus Biosystems Cashflow Statement
0.000.00%
- AU$4.26m
- AU$3.45m
- AU$0.08m
Annual cashflow statement for Vectus Biosystems, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.
2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | 2024 June 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Changes in Working Capital | 0.385 | 0.543 | 0 | 2.2 | 1.59 |
Other Operating Cash Flow | |||||
Cash from Operating Activities | -3 | -3.26 | -4.44 | -2.35 | -2.03 |
Capital Expenditures | — | — | -0.021 | -0.017 | -0.068 |
Purchase of Fixed Assets | |||||
Cash from Investing Activities | — | — | -0.021 | -0.017 | -0.068 |
Financing Cash Flow Items | -0.319 | -0.113 | 0 | -0.063 | 0 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 5.64 | 6.35 | -0.035 | 4.04 | -0.041 |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 2.64 | 3.09 | -4.5 | 1.67 | -2.14 |